Skip to content

Motor Control Training in Individuals With Subacromial Pain Syndrome

Motor Control Training in Individuals With Subacromial Pain Syndrome: Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04104906
Enrollment
34
Registered
2019-09-26
Start date
2019-06-17
Completion date
2020-01-30
Last updated
2021-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain

Keywords

Shoulder rehabilitation, Electromyography, Posture analysis

Brief summary

The porpusose of this study is to evaluate the repercussions of a motor control exercise protocol in patients with subacromial pain syndrome without indication of surgical repair.

Detailed description

Methods: This is a randomized controlled trial which will be composed of volunteers of both genders, aged between 35 and 60 years. All volunteers will undergo pre-assessment (Av1): pain sensation, pain and function, shoulder range of motion, muscle strength, electromyographic activity and kinematics of the shoulder complex. After the initial evaluation, the volunteers will be randomly divided into two groups to carry out the intervention: exercises (GE - conventional exercises with elastic band) and motor control (GCM - motor control training). The intervention protocol will last eight weeks. After four weeks, the second assessment (AV2), similar to AV1, will be performed and the global change perception questionnaire will be added. At the end of the intervention protocol, the third evaluation (AV3), similar to AV2, will be performed. A follow-up will be performed after 4 weeks of the end of the intervention protocol, with the assessment being equal to AV3. The project will be submitted to the Research Ethics Committee of the Federal University of Rio Grande do Norte through the national interface Plataforma Brasil. The study will also be registered on the international clinical trial platform, ClinicalTrials.gov. The study will only begin after approval of the ethics and research committee. All volunteers should read and sign the terms of free and informed consent.

Interventions

The volunteers of the motor control group will initiate the exercises on a stable and rigid basis. These will be progressed with adding an unstable base as the volunteer gains motor learning (between the fourth and fifth week of the protocol). For the motor control group, two sets of 10 repetitions will be performed keeping in isometry for ten seconds each repetition.

the protocol of strengthening and will have five elastic bands with different resistances available (extra-light, light, moderate, strong and extra-strong) for elbow flexion exercises progression, medial rotation and lateral rotation of the shoulder and scapular retraction.

Sponsors

Universidade Federal do Rio Grande do Norte
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Present subacromial pain with a score greater than or equal to 2 (Visual Analog Scale) for more than 2 months; * Positive Neer test; * Positive Hawkins test; * Positive Jobe test (pain); * Positive Patte test (pain); * Involvement of the supraspinatus and / or infraspinatus tendon (without degenerative characteristics) confirmed by Magnetic Nuclear Resonance (MRI) examination.

Exclusion criteria

* Intense pain during the evaluations; * Fail to properly perform the evaluation procedures; * Two consecutive or five alternating absences during the training protocol.

Design outcomes

Primary

MeasureTime frameDescription
Shoulder painChange from baseline in shoulder pain at 4 weeks, 8 weeks and follow up of 4 weeks after the intervention protocolEvaluation of pain level in the shoulder using the Numerical Pain Scale, graded from 0 to 10, where 0 indicates absence of pain and 10 indicates the worst pain imaginable.
Shoulder functionChange from baseline in shoulder function at 4 weeks, 8 weeks and follow up of 4 weeks after the intervention protocolEvaluation of shoulder pain and function using the Disabilities of the Arm, Shoulder and Hand (DASH). The questionnaire is a self-administered region-specific outcome instrument developed as a measure of self-rated upper-extremity disability and symptoms. The DASH consists mainly of a 30-item disability/symptom scale, scored 0 (no disability) to 100. The higher the score, the greater the functional disability.

Secondary

MeasureTime frameDescription
Peak of muscular torqueChange from baseline in peak of muscular torque at 4 weeks, 8 weeks and follow up of 4 weeks after the intervention protocolEvaluate the peak of muscular torque, by means of the manual dynamometer 8 weeks of the protocol and a follow up of 4 weeks.
Root Mean Square (RMS)Change from baseline in RMS at 4 weeks, 8 weeks and follow up of 4 weeks after the intervention protocolAnalyze of the electromyographic activity of the muscles shoulder complex, after 4 and 8 weeks of the protocol and a follow up of 4 weeks after the intervention protocol, by Root Mean Square (RMS)
Range of motionChange from baseline in range of motion at 4 weeks, 8 weeks and follow up of 4 weeks after the intervention protocolMeasure the range of motion for flexion, hyperextension, internal and external shoulder rotation 8 weeks of protocol and a follow up of 4 weeks, through the inclinometer.
Peak torque timeChange from baseline in peak torque time at 4 weeks, 8 weeks and follow up of 4 weeks after the intervention protocolEvaluate the peak torque time, using the manual dynamometer 8 weeks of the protocol and a follow up of 4 weeks.
The kinematics of the scapulaChange from baseline in kinematics of the scapular girdle at 4 weeks, 8 weeks and follow up of 4 weeks after the intervention protocolAnalyze the kinematics of the scapula and glenohumeral in the slow and habitual movements after 8 weeks of the protocol and a follow up of 4 weeks.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026